Curexo Inc. (KOSDAQ:060280)
9,100.00
+240.00 (2.71%)
Sep 19, 2025, 3:30 PM KST
Curexo Market Cap
Curexo has a market cap or net worth of 373.92 billion as of September 19, 2025. Its market cap has increased by 5.94% in one year.
Market Cap
373.92B
Enterprise Value
349.55B
Revenue
27.85B
Ranking
n/a
PE Ratio
n/a
Stock Price
9,100.00
Market Cap Chart
Since November 3, 2004, Curexo's market cap has increased from 3.98B to 373.92B, an increase of 9,289.05%. That is a compound annual growth rate of 24.29%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 19, 2025 | 373.92B | 40.87% |
Dec 30, 2024 | 265.44B | -65.17% |
Dec 28, 2023 | 762.19B | 191.52% |
Dec 29, 2022 | 261.46B | 5.49% |
Dec 30, 2021 | 247.86B | 18.34% |
Dec 30, 2020 | 209.44B | 32.32% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Samsung Biologics | 72.60T |
Celltrion | 37.16T |
ALTEOGEN | 26.35T |
Yuhan | 8,924.87B |
SK Biopharmaceuticals | 8,669.28B |
Peptron | 6,744.58B |
PharmaResearch | 6,524.70B |
ABL Bio | 5,528.46B |